A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
AI can spot signs of Alzheimer’s before your family does
Earlier diagnosis could help researchers develop drugs to slow the progress of the disease.
A simple artificial heart could permanently replace a failing human one
The small, streamlined design could have benefits over other devices.
A startup is pitching a mind-uploading service that is “100 percent fatal”
Nectome will preserve your brain, but you have to be euthanized first.